|  | DFS | OS | ||
---|---|---|---|---|---|
 |  | HR (95% CI) | p-value | HR (95% CI) | p-value |
Age at diagnosis (years) |  | 1.00 (0.98–1.02) | 0.691 | 1.01 (0.99–1.04) | 0.232 |
Method of detection | Screen-detected | 1.00 | Â | 1.00 | Â |
 | Symptomatic | 1.49 (0.91–2.47) | 0.115 | 1.30 (0.76–2.20) | 0.334 |
Stage at diagnosis | I-II | 1.00 | Â | 1.00 | Â |
 | III-IV | 2.41 (1.43–4.05) | 0.001 | 1.78 (1.00-3.18) | 0.05 |
Neoadjuvant chemotherapy | No neoadjuvant chemotherapy | 1.00 | Â | 1.00 | Â |
 | Yes, with a complete response | 1.88 (0.44–7.92) | 0.391 | 0.20 (0.04–1.05) | 0.06 |
 | Yes, with a partial or absent response | 2.24 (1.23–4.09) | 0.009 | 1.36 (0.64–2.86) | 0.413 |
Adjuvant chemotherapy | No | 1.00 | Â | 1.00 | Â |
 | Yes | 1.47 (0.82–2.64) | 0.200 | 0.86 (0.46–1.60) | 0.630 |
Type of surgery | Conservative | 1.00 | Â | 1.00 | Â |
 | Radical | 0.80 (0.48–1.34) | 0.405 | 0.99 (0.56–1.73) | 0.967 |
Vascular invasion | No | 1.00 | Â | 1.00 | Â |
 | Yes | 2.95 (1.67–5.20) | < 0.001 | 2.51 (1.36–4.62) | 0.003 |
Histologic type | Non-special type (NST) | 1.00 | Â | 1.00 | Â |
 | Metaplastic | 3.44 (1.46–8.10) | 0.005 | 2.73 (1.00-7.40) | 0.049 |
 | Lobular | 1.66 (0.60–4.58) | 0.330 | 1.84 (0.60–5.63) | 0.287 |
 | Others | 2.53 (1.41–4.53) | 0.002 | 2.62 (1.40–4.87) | 0.002 |
Histologic grade | 1–2 | 1.00 |  | 1.00 |  |
 | 3 | 0.69 (0.35–1.39) | 0.303 | 0.84 (0.41–1.75) | 0.647 |
Ki-67 | < 20% | 1.00 |  | 1.00 |  |
 | ≥ 20% | 1.54 (0.63–3.81) | 0.344 | 1.29 (0.47–3.55) | 0.619 |
TILS* | < 30% | 1.00 |  | 1.00 |  |
 | ≥ 30% | 1.00 (0.62–1.94) | 0.739 | 0.30 (0.12–0.76) | 0.011 |